Basics Bioventus Inc. IPO Date: February 11, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $505.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 3.12% Avg Daily Range (30 D): $0.16 | 2.25% Avg Daily Range (90 D): $0.16 | 2.23% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 193 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $1.17M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.66M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $1.31M Avg Closing Volume: 188.65K     News Aug 4, 2025 @ 12:00 PM Bioventus Enters into a New $400 Million Senior Se... Source: Dave Crawford Apr 10, 2025 @ 5:30 AM Intramedullary Nail Market size to worth USD 1,537... Source: Coherent Market Insights Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research Oct 4, 2024 @ 9:52 AM U.S. Osteoarthritis Injectables Market Analysis 20... Source: Researchandmarkets.Com Sep 24, 2024 @ 4:23 PM First September Gains in 5 Years? Buy 3 Breakout S... Source: Zacks Financials   TTM Q3 2025 Q2 2025 Basic EPS $.16 $.05 $.11 Diluted EPS $.16 $.05 $.11 Revenue $ 563.83M $ 138.65M $ 147.66M Gross Profit $ 382.03M $ 94.23M $ 102.09M Net Income / Loss $ 12.57M $ 4.01M $ 9.27M Operating Income / Loss $ 45.41M $ 11.25M $ 18.37M Cost of Revenue $ 181.8M $ 44.42M $ 45.57M Net Cash Flow $ -.91M $ 9.25M $ 10.11M PE Ratio 46.87